Literature DB >> 15267224

Peptide aptamers: specific inhibitors of protein function.

Felix Hoppe-Seyler1, Irena Crnkovic-Mertens, Evangelia Tomai, Karin Butz.   

Abstract

In recent years, peptide aptamers have emerged as novel molecular tools that are useful for both basic and applied aspects of molecular medicine. Due to their ability to specifically bind to and inactivate a given target protein at the intracellular level, they provide a new experimental strategy for functional protein analyses, both in vitro and in vivo. In addition, by using peptide aptamers as "pertubagens", they can be employed for genetic analyses, in order to identify biochemical pathways, and their components, that are associated with the induction of distinct cellular phenotypes. Furthermore, peptide aptamers may be developed into diagnostic tools for the detection of a given target protein or for the generation of high-throughput protein arrays. Finally, the peptide aptamer technology has direct therapeutic implications. Peptide aptamers can be used in order to validate therapeutic targets at the intracellular level. Moreover, the peptide aptamer molecules themselves should possess therapeutic potential, both as lead structures for drug design and as a basis for the development of protein drugs.

Mesh:

Substances:

Year:  2004        PMID: 15267224     DOI: 10.2174/1566524043360519

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  22 in total

Review 1.  Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Mohammed A Alsahli; Ghaiyda Talal Basfar; Faris Alrumaihi; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  3 Biotech       Date:  2020-11-24       Impact factor: 2.406

2.  Peptide aptamers that bind to a geminivirus replication protein interfere with viral replication in plant cells.

Authors:  Luisa Lopez-Ochoa; Jorge Ramirez-Prado; Linda Hanley-Bowdoin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  AAV-encoded CaV2.2 peptide aptamer CBD3A6K for primary sensory neuron-targeted treatment of established neuropathic pain.

Authors:  Hongwei Yu; Seung Min Shin; Hongfei Xiang; Dongman Chao; Yongsong Cai; Hao Xu; Rajesh Khanna; Bin Pan; Quinn H Hogan
Journal:  Gene Ther       Date:  2019-05-22       Impact factor: 5.250

4.  Dimerization and interactions of Brucella suis VirB8 with VirB4 and VirB10 are required for its biological activity.

Authors:  Athanasios Paschos; Gilles Patey; Durga Sivanesan; Chan Gao; Richard Bayliss; Gabriel Waksman; David O'callaghan; Christian Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

5.  Peptide aptamers that bind to geminivirus replication proteins confer a resistance phenotype to tomato yellow leaf curl virus and tomato mottle virus infection in tomato.

Authors:  Maria Ines Reyes; Tara E Nash; Mary M Dallas; J Trinidad Ascencio-Ibáñez; Linda Hanley-Bowdoin
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

Review 6.  Aptamers as therapeutics in cardiovascular diseases.

Authors:  P Wang; Y Yang; H Hong; Y Zhang; W Cai; D Fang
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

7.  In situ imaging and isolation of proteins using dsDNA oligonucleotides.

Authors:  Graham Dellaire; Rozalia Nisman; Christopher H Eskiw; David P Bazett-Jones
Journal:  Nucleic Acids Res       Date:  2004-11-23       Impact factor: 16.971

8.  A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.

Authors:  John Wojcik; Oliver Hantschel; Florian Grebien; Ines Kaupe; Keiryn L Bennett; John Barkinge; Richard B Jones; Akiko Koide; Giulio Superti-Furga; Shohei Koide
Journal:  Nat Struct Mol Biol       Date:  2010-03-28       Impact factor: 15.369

Review 9.  Aptamers against prion proteins and prions.

Authors:  Sabine Gilch; Hermann M Schätzl
Journal:  Cell Mol Life Sci       Date:  2009-04-25       Impact factor: 9.261

10.  Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.

Authors:  Nina Kaiser; Peter Lischka; Nadine Wagenknecht; Thomas Stamminger
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.